Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-27T07:35:12.240Z Has data issue: false hasContentIssue false

3 - Flow cytometry

from Part 1 - Diagnostic techniques

Published online by Cambridge University Press:  06 December 2010

By
Maryalice Stetler-Stevenson  and
Constance M. Yuan
Edited by
Wendy N. Erber
Wendy N. Erber
Affiliation:
University of Western Australia, Perth
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Diagnostic Techniques in Hematological Malignancies , pp. 51 - 70
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bourner, G, Dhaliwal, J, Sumner, JPerformance evaluation of the latest fully automated hematology analyzers in a large, commercial laboratory setting: a 4-way, side-by-side study. Lab Hematol 2005;11(4):285–97.CrossRefGoogle Scholar
Stetler-Stevenson, MAE, Barnett, D, Braylan, RCet al. Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline, 2nd Edn. CLSI document H43-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.Google Scholar
Braylan, RC, Orfao, A, Borowitz, MJ, Davis, BH. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry. 2001;461(1):23–7.3.0.CO;2-Z>CrossRefGoogle Scholar
Wood, B.Nine-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 2006;130(5):680–90.Google ScholarPubMed
Weir, EG, Cowan, K, LeBeau, P, Borowitz, MJ. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four-color flow cytometry: implications for residual disease detection. Leukemia 1999;13(4):558–67.CrossRefGoogle ScholarPubMed
Davis, BH, Holden, JT, Bene, MCet al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom 2007;72 Suppl. 1:S5–13.CrossRefGoogle ScholarPubMed
Orfao, A, Ortuno, F, Santiago, M, Lopez, A, San Miguel, JImmunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 2004;58(1):62–71.CrossRefGoogle ScholarPubMed
Hegde, U, Filie, A, Little, RFet al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005;105(2):496–502.CrossRefGoogle ScholarPubMed
Almasri, NM, Zaer, FS, Iturraspe, JA, Braylan, RC. Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens. Mod Pathol 1997;10(7):650–6.Google Scholar
Mourad, WA, Tulbah, A, Shoukri, Met al. Primary diagnosis and REAL/WHO classification of non-Hodgkin's lymphoma by fine-needle aspiration: cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2003;28(4):191–5.CrossRefGoogle ScholarPubMed
Stetler-Stevenson, M, Arthur, DC, Jabbour, Net al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98(4):979–87.CrossRefGoogle ScholarPubMed
Truong, F, Smith, BR, Stachurski, Det al. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study. Leuk Res 2009;33(8):1039–46.CrossRefGoogle ScholarPubMed
Valent, P, Horny, HP, Bennett, JMet al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007;31(6):727–36.CrossRefGoogle ScholarPubMed
Wells, DA, Benesch, M, Loken, MRet al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102(1):394–403.CrossRefGoogle ScholarPubMed
DiGiuseppe, JA, Borowitz, MJ. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 1998;25(1):6–10.Google ScholarPubMed
Nowakowski, GS, Witzig, TE, Dingli, Det al. Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma. Blood 2005;106(7):2276–9.CrossRefGoogle ScholarPubMed
Ocqueteau, M, Orfao, A, Almeida, Jet al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998;152(6):1655–65.Google ScholarPubMed
Duggan, PR, Easton, D, Luider, J, Auer, IA. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer 2000;88(4):894–9.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Del Poeta, G, Maurillo, L, Venditti, Aet al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001;98(9):2633–9.CrossRefGoogle ScholarPubMed
Wiestner, A, Rosenwald, A, Barry, TSet al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101(12):4944–51.CrossRefGoogle ScholarPubMed
Borowitz, MJ, Shuster, J, Carroll, AJet al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 1997;89(11):3960–6.Google Scholar
Jiang, L, Yuan, CM, Hubacheck, Jet al. Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy. Br J Haematol 2009;145(2):173–9.CrossRefGoogle ScholarPubMed
Perz, J, Topaly, J, Fruehauf, S, Hensel, M, Ho, AD. Level of CD20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia. Leukemia Lymphoma 2002;43(1):149–51.CrossRefGoogle ScholarPubMed
Coustan-Smith, E, Sancho, J, Hancock, MLet al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000;96(8):2691–6.Google ScholarPubMed
Rawstron, AC, Kennedy, B, Evans, PAet al. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood 2001;98(1):29–35.CrossRefGoogle ScholarPubMed
Kraan, J, Gratama, JW, Haioun, Cet al. Flow cytometric immunophenotyping of cerebrospinal fluid. Curr Protoc Cytom 2008;Chapter 6:Unit 6.25.
Wood, BL, Arroz, M, Barnett, Det al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytom B Clin Cytom 2007;72 Suppl. 1:S14–22.CrossRefGoogle ScholarPubMed
Jaffe, ES, Harris, NL, Stein, H, Vardiman, JW.Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Kleihues, PSL (ed.). Lyon: IARC Press; 2001.Google Scholar
Weir, EG, Borowitz, MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol 2001;38(2):124–38.CrossRefGoogle Scholar
Borowitz, MJ, Rubnitz, J, Nash, M, Pullen, DJ, Camitta, B.Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia 1998;12(11):1764–70.CrossRefGoogle ScholarPubMed
Zen, L, Orfao, A, Cazzaniga, Get al.Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia 2000;14(7):1225–31.CrossRefGoogle ScholarPubMed
Lee, RV, Braylan, R C, Rimsza, LM. CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia. Am J Clin Pathol 2005;123(1):119–24.CrossRefGoogle ScholarPubMed
Davis, RE, Longacre, TA, Cornbleet, PJ. Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings and differential diagnosis. Am J Clin Pathol 1994;102:202–11.CrossRefGoogle ScholarPubMed
Dunphy, CH. Comprehensive review of adult acute myelogenous leukemia: cytomorphological, enzyme cytochemical, flow cytometric immunophenotypic, and cytogenetic findings. J Clin Lab Analysis 1999;13(1):19–26.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Li, S, Juco, J, Mann, KP, Holden, JT. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 2004;121(2):268–74.CrossRefGoogle ScholarPubMed
Gorczyca, W, Tugulea, S, Liu, Zet al. Flow cytometry in the diagnosis of mediastinal tumors with emphasis on differentiating thymocytes from precursor T-lymphoblastic lymphoma/leukemia. Leukemia Lymphoma 2004;45(3):529–38.CrossRefGoogle Scholar
Raza, A, Jurcic, JG, Roboz, GJet al. Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial. Leukemia Lymphoma 2009; 50:1336–44.CrossRefGoogle ScholarPubMed
Hurwitz, CA, Raimondi, SC, Head, Det al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992;80(12):3182–8.Google Scholar
Baer, MR, Stewart, CC, Lawrence, Det al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood 1997;90(4):1643–8.Google Scholar
Kita, K, Nakase, K, Miwa, Het al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992;80(2):470–7.Google Scholar
Orfao, A, Chillon, MC, Bortoluci, AMet al. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RAR alpha gene rearrangements. Haematologica 1999;84(5):405–12.Google Scholar
Lin, P, Hao, S, Medeiros, LJet al. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol 2004;121(3):402–7.CrossRefGoogle ScholarPubMed
Kussick, SJ, Wood, BL.Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med 2003;127(9):1140–7.Google ScholarPubMed
Kussick, SJ, Wood, BL. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders. Am J Clin Pathol 2003;120(6):854–65.CrossRefGoogle ScholarPubMed
Stetler-Stevenson, M, Schrager, JA. Flow cytometric analysis in the diagnosis and prognosis of lymphoma and chronic leukemias. In McCoy, JP, Carey, JL, Keren, DF (eds.), Flow Cytometry in Clinical Diagnosis, 4th edn. Chicago: ASCP Press; 2006: 129–67.Google Scholar
Fukushima, PIN, Nguyen, PKT, O'Grady, P, Stetler-Stevenson, M. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry 1996;26:243–52.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Kussick, S, Kalnoski, M, Braziel, R, Wood, B. Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 2004;121:464–72.CrossRefGoogle ScholarPubMed
Marti, G, Rawstron, AC, Ghia, Pet al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325–32.CrossRefGoogle ScholarPubMed
Rawstron, A, Green, MJ, Kuzmicki, Aet al. Monoclonal B lymphocytes with the characteristics of indolent chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635–9.CrossRefGoogle ScholarPubMed
Maiese, RL, Segal, GH, Iturraspe, JA, Braylan, RC. The cell-surface antigen and DNA content distribution of lymph-nodes with reactive hyperplasia. Modern Pathol 1995;8(5):536–43.Google ScholarPubMed
Huang, J, Fan, G, Zhong, Yet al. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry. Am J Clin Pathol 2005;123:826–32.CrossRefGoogle ScholarPubMed
Kaleem, Z, Zehnbauer, BA, White, G, Zutter, MM. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas. Am J Clin Pathol 2000;113(3):399–405.CrossRefGoogle ScholarPubMed
Li, S, Eshleman, JR, Borowitz, MJ. Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B cell lymphoma. Am J Clin Pathol 2002;118:229–34.CrossRefGoogle ScholarPubMed
Cornfield, DB, Mitchell, DM, Almasri, NMet al. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20. Am J Clin Pathol 2000;114(2):258–63.CrossRefGoogle ScholarPubMed
Almasri, NM, Iturraspe, JA, Braylan, RC. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Archives Pathol Lab Med 1998;122(6):539–44.Google ScholarPubMed
Chen, X, Jensen, PE, Li, S. HLA-DO – A useful marker to distinguish florid follicular hyperplasia from follicular lymphoma by flow cytometry. Am J Clin Pathol 2003;119(6):842–51.CrossRefGoogle ScholarPubMed
Ginaldi, L, Martinis, M, Matutes, E, Farahat, N, Morilla, R. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 1998; 51:364–9.CrossRefGoogle ScholarPubMed
Yang, W, Agrawal, N, Patel, Jet al. Diminished expression of CD19 in B-cell lymphomas. Cytom B Clin Cytom 2005;63B:28–35.CrossRefGoogle Scholar
Kingma, DW, Imus, P, Xie, XYet al. CD2 is expressed by a sub-population of normal B cells and is frequently present in mature B-Cell neoplasms. Clin Cytom 2002;50:243–8.CrossRefGoogle Scholar
Kaleem, Z, White, G, Zutter, MM. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphoma. Am J Clin Pathol 2001;115:396–403.CrossRefGoogle Scholar
Foran, J, Norton, AJ, Micallef, INMet al. Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD-20): a retrospective cohort analysis. Br J Haematol 2001;114:881–3.CrossRefGoogle Scholar
Rawstron, AC, Orfao, A, Beksac, Met al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008;93(3):431–8.CrossRefGoogle ScholarPubMed
Ocqueteau, M, Orfao, A, Almeida, Jet al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998;152:1655–65.Google ScholarPubMed
Almeida, J, Orfao, A, Ocqueteau, Met al. High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma. Br J Haematol 1999;107:121–31.CrossRefGoogle ScholarPubMed
Konoplev, S, Medeiros, LJ, Bueso-Ramos, CE, Jorgensen, JL, Lin, P. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Am J Clin Pathol 2005;124:414–20.CrossRefGoogle ScholarPubMed
Lin, P, Owens, R, Tricot, G, Wilson, CS. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004;121:482–8.CrossRefGoogle ScholarPubMed
Rawstron, AC, Davies, FE, DasGupta, Ret al. Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood 2002;100(9):3095–100.CrossRefGoogle ScholarPubMed
Mateo, G, Montalban, MA, Vidriales, MBet al. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008;26(16):2737–44.CrossRefGoogle ScholarPubMed
Gorczyca, W, Weisberger, J, Liu, Zet al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Clinical Cytometry 2002;50B:177–90.CrossRefGoogle Scholar
Nicholson, JK, Rao, PE, Calvelli, Tet al. Artifactual staining of monoclonal antibodies in two-color combinations is due to an immunoglobulin in the serum and plasma. Cytometry 1994;18(3):140–6.CrossRefGoogle Scholar
McClanahan, J, Fukushima, PI, Stetler-Stevenson, M.Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: A diagnostic dilemma in flow cytometry. Cytometry 1999;38(6):280–5.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
Lima, M, Teixeira, MD, Queiros, MLet al. Immunophenotype and TCR-V beta repertoire of peripheral blood T-cells in acute infectious mononucleosis. Blood Cells Molecules Diseases 2003;10:1–12.CrossRefGoogle Scholar
Jamal, S, Picker, LJ, Aquino, DBet al. Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. Am J Clin Pathol 2001;116:512–26.CrossRefGoogle ScholarPubMed
Edelman, J, Meyerson, HJ. Diminished CD3 expression is useful for detecting and enumerating Sézary cells. Am J Clin Pathol 2000;114(3):467–77.CrossRefGoogle ScholarPubMed
Yokote, T, Akioka, T, Oka, Set al. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol 2005;124(2):199–204.CrossRefGoogle ScholarPubMed
Li, Y, Braylan, RC, Al-Quran, SZ. Flow-cytometric assessment of T-cell clonality in clinical specimens. LabMed 2007;38(8):477–82.Google Scholar
Beemd, RB, Boor, PPC, Lochem, EGet al. Flow cytometric analysis of the V beta repertoire in healthy controls. Cytometry 2000;40(4):336–45.3.0.CO;2-0>CrossRefGoogle Scholar
Ferenczi, K, Yawalkar, N, Jones, D, Kupper, TS. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy. Archives of Dermatology 2003;139(7):909–13.CrossRefGoogle ScholarPubMed
Morice, WG, Katzmann, JA, Pittelkow, MRet al. A comparison of morphologic features, flow cytometry, TCR-V-beta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome. Am J Clin Pathol 2006;125(3):364–74.CrossRefGoogle Scholar
Lima, M, Almeida, J, Montero, AGet al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004;165(4):1117–27.CrossRefGoogle ScholarPubMed
Husain, Z, Alper, CA, Yunis, EJ, Dubey, DP. Complex expression of natural killer receptor genes in single natural killer cells. Immunology 2002;106(3):373–80.CrossRefGoogle ScholarPubMed
Epling-Burnette, PK, Painter, JS, Chaurasia, Pet al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004;103(9):3431–9.CrossRefGoogle ScholarPubMed
Pascal, V, Schleinitz, N, Brunet, Cet al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. European J Immunol 2004;34(10):2930–40.CrossRefGoogle ScholarPubMed
Sawada, A, Sato, E, Koyama, Met al. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect. Am J Hematol 2006;81(8):576–81.CrossRefGoogle ScholarPubMed
Kussick, SJ, Fromm, JR, Rossini, Aet al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 2005;124(2):170–81.CrossRefGoogle ScholarPubMed
Maynadie, M, Picard, F, Husson, Bet al. Immunophenotypic clustering of myelodysplastic syndromes. Blood 2002;100(7):2349–56.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×